Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

Open in Screener

STAA

Staar Surgical Co

Jan 20 • 04:00PM ET

20.97

0.00 0.00 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: JNJ ALGN ISRG MDT ABT NVS BSX EW EYE SYK

| Held by: IJR IWM VTI VB VXF VBK SPSM IWO VTWO SCHA

Index	RUT	P/E	-	EPS (ttm)	-1.96	Insider Own	0.85%	Shs Outstand	49.35M	Perf Week	-4.73%
Market Cap	1.04B	Forward P/E	60.24	EPS next Y	0.35	Insider Trans	457.45%	Shs Float	49.32M	Perf Month	-19.00%
Enterprise Value	889.55M	PEG	1.65	EPS next Q	0.18	Inst Own	108.27%	Short Float	8.41%	Perf Quarter	-16.22%
Income	-96.37M	P/S	4.52	EPS this Y	-86.03%	Inst Trans	-6.39%	Short Ratio	3.10	Perf Half Y	18.07%
Sales	230.59M	P/B	2.93	EPS next Y	1060.40%	ROA	-19.39%	Short Interest	4.15M	Perf YTD	-9.18%
Book/sh	7.17	P/C	5.41	EPS next 5Y	36.48%	ROE	-24.65%	52W High	30.81 -31.94%	Perf Year	-4.05%
Cash/sh	3.87	P/FCF	-	EPS past 3/5Y	- -	ROIC	-24.86%	52W Low	13.50 55.33%	Perf 3Y	-70.17%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	10.85% 15.89%	Gross Margin	72.18%	Volatility	5.72% 5.27%	Perf 5Y	-76.55%
Dividend TTM	-	EV/Sales	3.86	EPS Y/Y TTM	-540.37%	Oper. Margin	-28.42%	ATR (14)	1.23	Perf 10Y	205.69%
Dividend Ex-Date	-	Quick Ratio	4.35	Sales Y/Y TTM	-32.42%	Profit Margin	-41.79%	RSI (14)	35.53	Recom	3.25
Dividend Gr. 3/5Y	- -	Current Ratio	5.21	EPS Q/Q	-12.41%	SMA20	-7.71%	Beta	1.07	Target Price	24.35
Payout	-	Debt/Eq	0.11	Sales Q/Q	6.93%	SMA50	-14.76%	Rel Volume	1.38	Prev Close	20.97
Employees	1211	LT Debt/Eq	0.10	Earnings	Nov 05 AMC	SMA200	-6.75%	Avg Volume	1.34M	Price	20.97
IPO	Jul 07, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	38.16% 0.03%	Trades		Volume	1,849,000	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-16-26	Resumed	Morgan Stanley	Underweight	$13
Apr-21-25	Initiated	Wells Fargo	Equal Weight	$17
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-12-25	Downgrade	Mizuho	Outperform → Neutral	$45 → $17
Feb-12-25	Downgrade	Jefferies	Buy → Hold
Feb-12-25	Downgrade	BTIG Research	Buy → Neutral
Jul-15-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$50 → $37
Jun-11-24	Upgrade	BTIG Research	Neutral → Buy	$46
Mar-11-24	Upgrade	Stifel	Hold → Buy	$30 → $50
Dec-05-23	Downgrade	Needham	Buy → Hold
Dec-04-23	Initiated	Morgan Stanley	Equal-Weight	$35
Sep-15-23	Downgrade	The Benchmark Company	Buy → Hold
Aug-03-23	Downgrade	Canaccord Genuity	Buy → Hold	$77 → $48
Jun-07-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-17-23	Initiated	Piper Sandler	Neutral	$65
Feb-06-23	Downgrade	BTIG Research	Buy → Neutral
Dec-28-22	Reiterated	BTIG Research	Buy	$80 → $67
Dec-08-22	Initiated	Stifel	Hold	$60
Nov-07-22	Upgrade	Sidoti	Neutral → Buy
Oct-14-22	Resumed	Stephens	Overweight	$91

Show Previous Ratings

Jan-16-26 08:39PM	Staar Surgical, Alumis, and More Stocks See Action From Activist Investors (Barrons.com)
09:32AM	Seagate upgraded, Tractor Supply downgraded: Wall Street's top analyst calls (The Fly)
08:02AM	Here Are Fridays Top Wall Street Analyst Research Calls: ConocoPhillips, Devon Energy, Garmin, Honeywell, HP, PepsiCo, Rocket Labs, Seagate, and More (24/7 Wall St.)
05:00AM	STAAR CEO exits after company rejects Alcon buyout (MedTech Dive)
Jan-15-26 11:04PM	STAAR Surgical (STAA): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
01:06PM	Loading…
01:06PM	STAAR Surgical Stock Falls After Largest Shareholder Broadwood Gains Board Influence (Benzinga)
08:30AM	STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement (Business Wire)
Jan-13-26 08:45AM	Mitsui Sumitomo Continues to Build WR Berkley Stake (24/7 Wall St.)
Jan-07-26 07:38AM	STAAR Surgical terminates Alcon merger agreement (Medical Device Network)
Jan-06-26 08:00PM	Alcon Terminates Agreement to Acquire STAAR Surgical (Business Wire) -6.91%
12:32PM	Health Care Roundup: Market Talk (The Wall Street Journal)
12:14PM	Exclusive: STAAR Surgical deal fails as shareholder support remains at around 30% (Investing.com)
09:52AM	Broadwood Partners Comments on STAAR Surgical Shareholders Rejection of the Companys Proposed Sale to Alcon (Business Wire)
08:47AM	STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders (Business Wire)
06:13AM	STAAR shareholders reject Alcons revised buyout offer (MedTech Dive)
03:51PM	Loading…
Dec-19-25 03:51PM	Exclusive: STAAR merger with Alcon still fails to gain traction, only 30% vote for (Investing.com)
12:59PM	Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon (Business Wire)
11:45AM	Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders (Business Wire)
Dec-17-25 06:47PM	Broadwood sees $50/share path for STAAR Surgical as merger battle nears voting day (Investing.com) -7.22%
04:53PM	Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc. (PR Newswire)
01:17PM	Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails (Business Wire)
10:55AM	STAAR Stockholders Have a Choice: Vote FOR Alcon's Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value (Business Wire)
Dec-16-25 03:58PM	ISS recommends STAAR Surgical deal, but warns shareholders have reason to object (Investing.com) +5.26%
01:32PM	Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory (Business Wire)
09:12AM	Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction (Business Wire)
07:00AM	Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon (Business Wire)
Dec-15-25 06:35PM	Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote "FOR" Alcon Merger (Business Wire)
Dec-12-25 05:29PM	Battle for STAAR Surgical intensifies as Glass Lewis reiterates stance against (Investing.com)
08:40AM	Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation "AGAINST" STAAR Surgical Sale to Alcon (Business Wire)
Dec-11-25 08:06PM	STAAR Surgical accuses activist Broadwood of misinformation campaign (Investing.com)
11:41AM	Loading…
11:41AM	Why STAAR Surgical (STAA) Stock Is Up Today (StockStory)
09:47AM	STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process (Business Wire)
07:00AM	Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon (Business Wire)
Dec-10-25 01:34PM	STAAR Surgical falls as Yunqi Capital reiterates opposition to merger with Alcon (Investing.com) -5.50%
07:05AM	Yunqi Capital Comments on STAAR Surgical's Go-Shop Process and Alcon's Revised Offer (Business Wire)
Dec-09-25 02:25PM	Alcon bumps STAAR Surgical bid to $30.75, but Broadwood remains vehemently against (Investing.com) +7.84%
02:16PM	STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know (StockStory)
12:39PM	Broadwood Partners Responds to Alcon's Increase to Proposed Acquisition Price of STAAR Surgical (Business Wire)
12:00PM	What Makes Staar Surgical (STAA) a New Buy Stock (Zacks)
08:30AM	Alcon Announces Amended Merger Agreement with STAAR Surgical (Business Wire)
Dec-08-25 04:11PM	Why STAAR Surgical (STAA) Shares Are Plunging Today (StockStory) -7.25%
01:28PM	Broadwood Partners Reiterates Opposition to STAAR Surgical's Sale to Alcon Following Conclusion of Performative Go-Shop Process (Business Wire)
08:16AM	Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote "AGAINST" Sale to Alcon (Business Wire)
08:00AM	STAAR Surgical Announces Expiration of Go-Shop Period (Business Wire)
Dec-04-25 10:35PM	STAAR Surgical (NASDAQ:STAA) Q3 Earnings: Leading The Medical Devices & Supplies - Specialty Pack (StockStory)
Dec-03-25 12:02PM	Broadwood reiterates push for STAAR Surgical board shake-up as Alcon vote nears (Investing.com)
Dec-02-25 04:14PM	Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors (Business Wire)
Nov-26-25 03:34PM	Staar Surgical, Gold Royalty See Activist Action (Barrons.com)
Nov-18-25 04:15PM	STAAR Surgical reveals board dissent over amended Alcon deal ahead of vote (Investing.com)
Nov-12-25 02:35PM	Exclusive: Broadwood says Alcons earnings reveal STAAR bid came from weakness (Investing.com) -5.66%
Nov-10-25 06:38PM	Broadwood continues pressure on STAAR board, urges new directors amid go-shop move (Investing.com)
01:00PM	STAARs largest shareholder requests new directors in ongoing Alcon merger dispute (Medical Device Network)
08:00AM	Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process (Business Wire)
Nov-07-25 04:22PM	STAAR Surgical opens go-shop window amid shareholder revolt over Alcon deal (Investing.com)
10:10AM	STAAR Surgical Announces Amendments to Alcon Merger Agreement (Business Wire)
Nov-06-25 06:21AM	Yunqi Capital Applauds STAAR Surgicals Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated (Business Wire) +5.47%
Nov-05-25 04:27PM	Staar Surgical: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	STAAR Surgical Reports Third Quarter 2025 Results (Business Wire)
Nov-04-25 11:32PM	3 Stocks Under $50 We Keep Off Our Radar (StockStory)
03:13PM	Alcon, Broadwood trade blows in fight for STAAR Surgicals future (Investing.com)
11:52AM	Broadwood Partners Condemns Alcon's Fallacious Attacks on STAAR Surgical and Its Prospects (Business Wire)
01:00AM	Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders (Business Wire)
Oct-31-25 12:00PM	Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon (Business Wire)
11:14AM	Alcon rejects raised bid for STAAR Surgical as shareholders revolt (Investing.com)
Oct-27-25 04:43PM	Short Sellers Are Targeting Small-Caps. Megacaps Are Getting a Pass. (Barrons.com) +5.75%
08:00AM	STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon (Business Wire)
Oct-24-25 06:03PM	Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon (Business Wire)
01:59PM	Exclusive: Roughly 72% of STAAR Surgical shares oppose Alcon deal, vote delayed (Investing.com)
08:00AM	Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction (Business Wire)
Oct-23-25 12:09PM	Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders (Business Wire) +8.27%
Oct-22-25 02:35PM	Broadwood moves to oust STAAR Surgical directors over Alcon deal (Investing.com) -6.71%
06:17AM	Broadwood Partners Intends to Call Special Meeting to Remove Several STAAR Surgical Directors (Business Wire)
Oct-20-25 05:32PM	Yunqi Capital Issues Letter to STAAR Surgical's Board Calling for Timely Convening of the Special Meeting to Vote on the Alcon Transaction (Business Wire) +5.41%
08:42AM	Broadwood Partners Highlights Growing Opposition to STAAR Surgicals Proposed Sale to Alcon (Business Wire)
07:30AM	STAAR Surgical Announces Preliminary Net Sales Results for Third Quarter 2025 (Business Wire)
Oct-17-25 08:00AM	Broadwood Partners Issues Letter to STAAR Surgical's Board Urging it to Allow Timely Shareholder Vote on Alcon Sale (Business Wire)
Oct-16-25 06:54PM	ISS recommendation may toll the bell for STAARAlcon deal, validates Broadwood (Investing.com) -5.97%
04:15PM	STAAR Surgical Affirms that No Acquisition Proposals Have Been Received From Any Party Other Than Alcon (Business Wire)
Oct-15-25 01:36PM	Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote "AGAINST" Sale to Alcon (Business Wire)
Oct-14-25 02:29PM	Broadwood Partners Comments on STAAR Surgical's Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon (Business Wire)
Oct-12-25 08:02PM	Broadwood slams STAAR board over carelessness in Alcon sale defense (Investing.com)
Oct-10-25 01:11PM	Broadwood Partners Issues Letter to STAAR Surgical's Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale (Business Wire)
Oct-09-25 09:28AM	Glass Lewis recommends against STAARAlcon merger, bolstering Broadwoods campaign (Investing.com)
Oct-08-25 11:40AM	STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote "FOR" the Alcon Merger Agreement on WHITE Proxy Card (Business Wire)
11:16AM	Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote AGAINST Sale to Alcon (Business Wire)
08:00AM	Broadwood Partners Questions Integrity of STAAR Surgical's Last-Minute Forecast Change and Fairness Opinion in Sale to Alcon (Business Wire)
Oct-07-25 11:25AM	Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon (PR Newswire)
Oct-06-25 04:01PM	Yunqi Capital, One of STAAR Surgical Company's Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon (Business Wire)
08:29AM	Broadwood Partners Issues Letter to STAAR Surgical's Board Questioning Its Judgment in Proposed Sale to Alcon (Business Wire)
07:31AM	STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis (Business Wire)
07:30AM	STAAR Surgical Addresses Broadwood Partners' Flawed, Misleading, and Misinformed Claims (Business Wire)
Oct-03-25 06:00AM	Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgicals Sale to Alcon (Business Wire)
Sep-30-25 08:30AM	Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon's Acquisition of STAAR (Business Wire)
Sep-29-25 03:56PM	Broadwood files definitive proxy, STAAR reaffirms Alcon merger (Investing.com)
Sep-26-25 05:56PM	Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors (Barrons.com)
08:00AM	STAAR Surgical Publishes Presentation Highlighting Compelling, Certain Cash Value Offered by Alcon Merger and Meaningful Downside Risks if Alcon Merger is not Approved (Business Wire)
12:03AM	3 Reasons to Avoid STAA and 1 Stock to Buy Instead (StockStory)
Sep-24-25 08:00AM	Broadwood Partners Files Definitive Proxy Statement Soliciting STAAR Surgical Stockholders to Vote "AGAINST" Proposed Acquisition by Alcon (Business Wire)
Sep-22-25 04:43PM	STAAR draws no rival bids as Yunqi joins Broadwood against Alcon deal (Investing.com)
07:15AM	STAAR Surgical Announces Expiration of Window Shop Period; No Competing Acquisition Proposals Received (Business Wire)

STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jiang Wei	Director	Jan 12 '26	Option Exercise	0.00	20,967	0	66,444	Jan 14 05:48 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 09 '26	Buy	22.05	27,485	606,138	15,453,629	Jan 13 09:30 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 06 '26	Buy	21.62	336,946	7,284,281	15,356,437	Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 07 '26	Buy	22.00	66,467	1,462,301	15,422,904	Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 08 '26	Buy	21.94	3,240	71,082	15,426,144	Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 21 '25	Buy	27.86	797,486	22,218,837	15,019,491	Nov 21 09:55 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 20 '25	Buy	27.14	393,382	10,675,325	14,222,005	Nov 21 09:55 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 19 '25	Buy	26.42	309,132	8,166,155	13,828,623	Nov 21 09:55 PM
Jiang Wei	Director	Nov 12 '25	Option Exercise	0.00	20,967	0	45,477	Nov 14 06:00 PM
Jiang Wei	Director	Aug 12 '25	Option Exercise	0.00	20,967	0	24,510	Aug 13 06:39 PM
WEISNER AIMEE S	Former Director	Aug 05 '25	Proposed Sale	26.87	1,750	47,025		Aug 05 06:38 PM
WEISNER AIMEE S	Former Director	Aug 05 '25	Proposed Sale	26.87	13,491	362,523		Aug 05 06:33 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 08 '25	Buy	15.32	178,127	2,729,095	13,510,391	Apr 10 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 09 '25	Buy	15.08	8,200	123,676	13,518,591	Apr 10 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 10 '25	Buy	15.18	900	13,658	13,519,491	Apr 10 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 04 '25	Buy	15.91	497,631	7,917,191	13,194,210	Apr 07 08:28 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 03 '25	Buy	16.97	209,535	3,555,138	12,696,579	Apr 07 08:28 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 07 '25	Buy	15.61	138,054	2,155,174	13,332,264	Apr 07 08:28 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 02 '25	Buy	17.43	31,780	553,925	12,487,044	Apr 02 08:33 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 31 '25	Buy	17.46	22,189	387,360	12,455,264	Apr 02 08:33 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 26 '25	Buy	17.50	101,633	1,778,517	12,421,324	Mar 28 06:45 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 28 '25	Buy	17.47	8,131	142,014	12,433,075	Mar 28 06:45 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 27 '25	Buy	17.48	3,620	63,294	12,424,944	Mar 28 06:45 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 21 '25	Buy	17.74	102,400	1,816,545	12,285,395	Mar 25 07:02 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 25 '25	Buy	17.44	34,296	598,177	12,319,691	Mar 25 07:02 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 20 '25	Buy	17.96	108,720	1,952,992	12,182,995	Mar 20 07:51 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 18 '25	Buy	17.54	93,124	1,633,291	12,074,275	Mar 20 07:51 PM
Foust Warren	Chief Operating Officer	Mar 12 '25	Option Exercise	0.00	8,175	0	26,088	Mar 14 07:24 PM
Michna Magda	Chief Clinical, Regulatory,	Mar 12 '25	Option Exercise	0.00	6,177	0	18,554	Mar 14 07:21 PM
SISITSKY NATHANIEL	General Counsel	Mar 12 '25	Option Exercise	0.00	5,827	0	27,762	Mar 14 07:20 PM
Williams Patrick F.	Chief Financial Officer	Mar 12 '25	Option Exercise	0.00	8,153	0	56,242	Mar 14 07:19 PM
Williams Patrick F.	Chief Financial Officer	Mar 10 '25	Option Exercise	0.00	4,061	0	48,089	Mar 11 08:40 PM
Williams Patrick F.	Chief Financial Officer	Mar 07 '25	Option Exercise	0.00	5,689	0	44,028	Mar 11 08:40 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 04 '25	Buy	17.24	27,953	481,849	11,981,151	Mar 06 07:07 PM
FARRELL STEPHEN C	President & CEO	Mar 05 '25	Option Exercise	6.95	20,000	138,900	35,156	Mar 06 05:47 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 27 '25	Buy	17.05	259,316	4,420,106	11,548,753	Mar 03 07:12 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 03 '25	Buy	16.64	249,503	4,151,214	11,953,198	Mar 03 07:12 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 28 '25	Buy	17.45	154,942	2,704,235	11,703,695	Mar 03 07:12 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 12 '25	Buy	14.96	259,616	3,883,255	11,137,623	Feb 14 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 13 '25	Buy	15.84	115,282	1,825,514	11,252,905	Feb 14 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 14 '25	Buy	15.49	36,532	565,998	11,289,437	Feb 14 07:00 PM

Open in Screener

LNSR

LENSAR Inc

Jan 20 • 04:00PM ET

12.00

+0.10 0.84 %

Healthcare • Medical Devices • USA • NASD

Peers: STAA ICUI IART CERS ATEC HAE MLAB CUTR LMAT

| Held by: VTI IWM VXF IWO VTWO IWC DFAS GSSC DFAT VTWG

Index	RUT	P/E	-	EPS (ttm)	-4.39	Insider Own	21.40%	Shs Outstand	11.94M	Perf Week	3.99%
Market Cap	143.33M	Forward P/E	3076.92	EPS next Y	0.00	Insider Trans	0.00%	Shs Float	9.39M	Perf Month	0.59%
Enterprise Value	143.12M	PEG	-	EPS next Q	-0.07	Inst Own	49.39%	Short Float	8.02%	Perf Quarter	1.27%
Income	-51.52M	P/S	2.42	EPS this Y	-2.86%	Inst Trans	2.21%	Short Ratio	14.06	Perf Half Y	-9.91%
Sales	59.14M	P/B	-	EPS next Y	100.14%	ROA	-77.94%	Short Interest	0.75M	Perf YTD	3.18%
Book/sh	-2.17	P/C	8.50	EPS next 5Y	-	ROE	-422.35%	52W High	17.31 -30.68%	Perf Year	40.02%
Cash/sh	1.41	P/FCF	-	EPS past 3/5Y	-9.25% -14.63%	ROIC	-	52W Low	8.08 48.51%	Perf 3Y	365.12%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	15.79% 11.87%	Gross Margin	44.59%	Volatility	2.02% 2.54%	Perf 5Y	68.78%
Dividend TTM	-	EV/Sales	2.42	EPS Y/Y TTM	-200.88%	Oper. Margin	-35.42%	ATR (14)	0.32	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.67	Sales Y/Y TTM	21.02%	Profit Margin	-87.12%	RSI (14)	60.69	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.24	EPS Q/Q	-138.25%	SMA20	2.02%	Beta	0.69	Target Price	10.00
Payout	-	Debt/Eq	-	Sales Q/Q	5.74%	SMA50	7.85%	Rel Volume	0.34	Prev Close	11.90
Employees	140	LT Debt/Eq	-	Earnings	Nov 06 BMO	SMA200	-3.68%	Avg Volume	53.55K	Price	12.00
IPO	Oct 02, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	17,945	Change	0.84%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-24-21	Initiated	SVB Leerink	Outperform	$20

Nov-06-25 07:00AM	LENSAR Reports Third Quarter 2025 Results and Provides Business Update (GlobeNewswire) -8.63%
Sep-02-25 04:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-07-25 07:00AM	LENSAR Reports Second Quarter 2025 Results and Provides Business Update (GlobeNewswire)
Jul-01-25 04:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-02-25 04:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
07:00AM	Loading…
May-08-25 07:00AM	LENSAR Reports First Quarter 2025 Results and Provides Business Update (GlobeNewswire)
Apr-24-25 09:20AM	LENSAR: It Is All About The Contingent Value Right Now (Seeking Alpha)
Apr-10-25 01:59PM	Alcon: A Clear Vision, But Fully Valued (Seeking Alpha)
08:35AM	Is LENSAR (LNSR) a Deeply Undervalued Stock? (Insider Monkey)
Mar-25-25 09:00AM	Morning Movers: 23andMe plummets after Chapter 11 proceedings and CEO exit (TipRanks)
08:35AM	ALC Stock Rises Following the Merger Agreement With LENSAR (Zacks)
Mar-24-25 08:00AM	Alcon Agrees to Acquire LENSAR, Inc. (GlobeNewswire)
Mar-03-25 07:03PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-28-25 02:17AM	LENSAR Inc (LNSR) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... (GuruFocus.com) +19.60%
Feb-27-25 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update (GlobeNewswire) +14.78%
08:18AM	Loading…
Feb-26-25 08:18AM	Earnings To Watch: LENSAR Inc (LNSR) Reports Q4 2024 Result (GuruFocus.com)
Feb-19-25 12:00PM	LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025 (GlobeNewswire)
Feb-03-25 07:33PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.63%
Jan-02-25 06:08PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-09-24 04:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-26-24 08:00AM	LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day (GlobeNewswire)
Nov-08-24 02:14AM	LENSAR Inc (LNSR) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion (GuruFocus.com) +7.42%
Nov-07-24 07:00AM	LENSAR Reports Third Quarter 2024 Results and Provides Business Update (GlobeNewswire) +17.24%
Nov-06-24 07:53AM	LENSAR Inc (LNSR) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Nov-01-24 06:32PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.28% +8.92%
Oct-31-24 07:00AM	LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024 (GlobeNewswire)
Oct-09-24 08:15AM	Lensar announces more than 1M procedures completed with cataract laser systems (TipRanks)
Oct-08-24 08:00AM	One Millionth Procedure Completed Using LENSAR's Cataract Laser Systems (GlobeNewswire) +6.11%
Oct-01-24 06:25PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-04-24 04:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:00AM	Loading…
08:00AM	LENSAR to Participate in Two Upcoming Investor Conferences (Business Wire)
Aug-08-24 07:00AM	LENSAR Reports Second Quarter 2024 Results and Provides Business Update (Business Wire) -9.93%
Aug-07-24 07:00AM	LENSAR Announces Certification for the ALLY Adaptive Cataract Treatment System in the European Union (Business Wire) -7.90%
Aug-01-24 06:42PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
07:00AM	LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 (Business Wire)
Jul-05-24 10:00AM	3 Under-$10 Stocks With the Potential to Make You a Millionaire (InvestorPlace)
Jul-02-24 05:50PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +5.80%
Jun-03-24 06:34PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -7.33%
May-23-24 08:00AM	LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference (Business Wire)
May-13-24 11:14AM	LENSAR, Inc. (NASDAQ:LNSR) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 11:57AM	LNSR Stock Earnings: LENSAR Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +12.68%
07:00AM	LENSAR Reports First Quarter 2024 Results and Provides Business Update (Business Wire)
May-02-24 08:00AM	LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 (Business Wire)
May-01-24 06:38PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-01-24 06:28PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-05-24 09:11AM	LENSAR, Inc. (NASDAQ:LNSR) Q4 2023 Earnings Call Transcript (Insider Monkey) -10.97%
Mar-04-24 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update (Business Wire)
Mar-01-24 05:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-26-24 08:00AM	LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024 (Business Wire)
Nov-12-23 09:38AM	LENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 07:00AM	LENSAR Reports Third Quarter 2023 Results and Provides Business Update (Business Wire) +12.44%
Nov-02-23 08:03AM	LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023 (Business Wire) +5.12%
Aug-09-23 07:00AM	LENSAR Reports Second Quarter 2023 Results and Provides Business Update (Business Wire) +12.73%
Jul-24-23 07:00AM	LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups (Business Wire)
May-15-23 07:00AM	LENSAR Reports First Quarter 2023 Results and Provides Business Update (Business Wire) -9.45%
May-10-23 08:00AM	LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023 (Business Wire)
Mar-20-23 03:05AM	LENSAR, Inc. (NASDAQ:LNSR) Q4 2022 Earnings Call Transcript (Insider Monkey) -10.98%
Mar-16-23 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update (Business Wire)
Mar-09-23 08:00AM	LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023 (Business Wire)
Feb-14-23 07:00AM	LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results (Business Wire)
Nov-22-22 08:00AM	LENSAR to Present at Two Upcoming Investor Conferences (Business Wire)
Nov-09-22 07:00AM	LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update (Business Wire) -11.56%
Nov-02-22 08:00AM	LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022 (Business Wire)
Sep-08-22 07:00AM	LENSAR Announces Application for Certification of the ALLY Adaptive Cataract Treatment System in the EU (Business Wire)
Aug-16-22 07:00AM	First Patients Treated with LENSARs® ALLY Adaptive Cataract Treatment System (Business Wire)
Aug-08-22 07:00AM	LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update (Business Wire)
Aug-01-22 08:00AM	LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022 (Business Wire)
Jun-13-22 07:00AM	LENSAR® Receives U.S. FDA Clearance of ALLY Adaptive Cataract Treatment System (Business Wire)
Jun-09-22 07:30AM	Shareholders in LENSAR (NASDAQ:LNSR) are in the red if they invested a year ago (Simply Wall St.)
May-09-22 07:00AM	LENSAR Reports First Quarter 2022 Financial Results and Provides Business Update (Business Wire)
May-02-22 08:00AM	LENSAR to Report First Quarter 2022 Financial Results on Monday, May 9, 2022 (Business Wire)
Apr-21-22 09:08AM	We're Not Very Worried About LENSAR's (NASDAQ:LNSR) Cash Burn Rate (Simply Wall St.)
Mar-03-22 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (Business Wire) +6.34%
Mar-01-22 07:00AM	LENSAR Announces U.S. Food and Drug Administration Acceptance of 510(k) Submission for ALLY (Business Wire)
Feb-28-22 04:01PM	LENSAR to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 3, 2022 (Business Wire)
Feb-23-22 02:01AM	Should Now Consider Selling Your LENSAR (LNSR) Shares? (Insider Monkey)
Feb-10-22 08:00AM	LENSAR to Participate in Two Upcoming Investor Conferences (Business Wire)
Jan-04-22 08:00AM	LENSAR to Present at the H.C. Wainwright Virtual BioConnect Conference (Business Wire)
Dec-31-21 07:53AM	Shareholders in LENSAR (NASDAQ:LNSR) are in the red if they invested a year ago (Simply Wall St.)
Nov-16-21 08:00AM	LENSAR to Present at Two Upcoming Investor Conferences (Business Wire)
Nov-12-21 07:00AM	LENSAR Announces Poster Presentations at the American Academy of Ophthalmology (Business Wire)
Nov-08-21 07:00AM	LENSAR Reports Third Quarter 2021 Financial Results and Provides Business Update (Business Wire)
Nov-01-21 08:00AM	LENSAR to Report Third Quarter 2021 Financial Results on Monday, November 8, 2021 (Business Wire)
Oct-02-21 10:32AM	We Think LENSAR (NASDAQ:LNSR) Can Afford To Drive Business Growth (Simply Wall St.)
Sep-02-21 08:00AM	LENSAR to Present at the H.C. Wainwright 23rd Annual Global Investment Conference (Business Wire)
Aug-16-21 08:00AM	LENSAR to Present at the H.C. Wainwright Ophthalmology Virtual Conference (Business Wire)
Aug-05-21 07:00AM	LENSAR Reports Second Quarter 2021 Financial Results and Provides Business Update (Business Wire)
Jul-29-21 08:00AM	LENSAR to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021 (Business Wire)
Jul-15-21 08:00AM	LENSAR Announces In-Person Demonstrations of Its Next Generation ALLY System and Multiple Data Presentations at the American Society of Cataract and Refractive Surgery (ASCRS) 2021 Annual Meeting (Business Wire)
May-24-21 08:00AM	LENSAR to Present at the Oppenheimer MedTech, Tools, & Diagnostics Summit (Business Wire)
May-05-21 07:00AM	LENSAR Reports First Quarter 2021 Financial Results and Provides Business Update (Business Wire)
06:45AM	LENSAR Inc to Host Earnings Call (ACCESSWIRE)
Apr-28-21 08:00AM	LENSAR to Hold First Quarter 2021 Financial Results Conference Call on Wednesday, May 5, 2021 (Business Wire)
Mar-10-21 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update (Business Wire) +5.58%
Mar-03-21 04:05PM	LENSAR to Hold Fourth Quarter and Full Year 2020 Financial Results and Business Update Conference Call on Wednesday, March 10, 2021 (Business Wire) -6.13%
Feb-16-21 01:28PM	Is LENSAR Inc. (LNSR) A Smart Long-Term Buy? (Insider Monkey)
Feb-08-21 08:00AM	LENSAR to Present at Two Upcoming Investor Conferences (Business Wire) +8.67%
Feb-01-21 07:00AM	LENSAR Expands Board of Directors with the Appointments of Aimee S. Weisner and Elizabeth G. OFarrell (Business Wire)
Jan-03-21 03:58AM	We Think LENSAR (NASDAQ:LNSR) Needs To Drive Business Growth Carefully (Simply Wall St.)
Nov-23-20 08:00AM	LENSAR to Present at the 32nd Annual Piper Sandler Virtual Healthcare Conference (Business Wire)

LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.

STAA

Staar Surgical Co

LNSR

LENSAR Inc

Upgrade your FINVIZ experience